Influence of Dapagliflozin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Open Access
- 1 January 2016
- journal article
- research article
- Published by Hindawi Limited in Journal of Diabetes Research
- Vol. 2016, 1-6
- https://doi.org/10.1155/2016/5347262
Abstract
Objectives. To observe changes in blood glycemic variations and oxidative stress level before and after dapagliflozin treatment in patients with newly diagnosed T2DM.Methods. This was a randomized, double-blind, placebo-controlled, phase 3 trial. A total of 28 patients with newly diagnosed T2DM withlevels of 7.5–10.5% were randomly selected to receive dapagliflozin or placebo treatment for 24 weeks. After baseline data were collected, we analyzed glycemic variations and plasma 8-iso PGF2αlevel at baseline and at the endpoint. Primary outcome was the changes of mean amplitude glycemic excursion (MAGE) within groups.Results. After 24-week dapagliflozin therapy, our data showed the significant improvement of MAGE with dapagliflozin therapy (). Compared with control group, patients in dapagliflozin group exhibited reduction in 24-hour MBG () and lower mean plasma glucose concentrations, especially during periods from 2400 to 0200 and 1300 to 1800 (, resp.). In addition, plasma 8-iso PGF2αlevel was notably decreased in the treatment group compared to the control group ().Conclusions.In conclusion, this study shows the ability of dapagliflozin to improve glycemic variations and associate with reduction of oxidative stress in patients with T2DM, which may benefit the cardiovascular system.
Keywords
Funding Information
- Nanjing Public Health Bureau Project (YKK11110, BL2014010, 2015M581829)
This publication has 40 references indexed in Scilit:
- Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetesDiabetes, Obesity and Metabolism, 2013
- SGLT2 inhibition in diabetes mellitus: rationale and clinical prospectsNature Reviews Endocrinology, 2012
- Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With MetforminDiabetes Care, 2011
- Effect of Exenatide on Inflammatory and Oxidative Stress Markers in Patients with Type 2 Diabetes MellitusDiabetes Technology & Therapeutics, 2011
- Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetesAtherosclerosis, 2010
- Implications of Postprandial Glucose and Weight Control in People With Type 2 DiabetesDiabetes Care, 2009
- Reference Values for Continuous Glucose Monitoring in Chinese SubjectsDiabetes Care, 2009
- Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic PatientsDiabetes, 2008
- Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian originDiabetologia, 2004
- Hyperglycemie and Microvascular and Macrovascular Disease in DiabetesDiabetes Care, 1995